Evidence map›Paper›PMID 34142081›Full record

ArticleClinical oncology and research2020

What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.

Denise Garcia, Julie B Siegel, David A Mahvi, Biqi Zhang, David M Mahvi, E Ramsay Camp, Whitney Graybill, Stephen J Savage, Antonio Giordano, Sara Giordano and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical oncology and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. The COVID-19 Pandemic and Cancer Surgery.Indian journal of surgical oncology · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Denise Garcia *Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Julie B Siegel *Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
David A MahviDepartment of Surgery, Brigham and Women's Hospital, Boston, Boston, Massachusetts, USA.
Biqi ZhangDepartment of Surgery, Brigham and Women's Hospital, Boston, Boston, Massachusetts, USA.
David M MahviDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
E Ramsay CampDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Whitney GraybillDepartment of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina, USA.
Stephen J SavageDepartment of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.
Antonio GiordanoDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Sara GiordanoDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Denise Carneiro-PlaDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Mahsa JavidDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Aaron P LesherDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Andrea AbbottDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Nancy Klauber DeMoreDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Medical University of South Carolina · USBrigham and Women's Hospital · US

Funding

Integrative Training in Oncogenic SignalingT32CA193201 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWE, PHILIP H, LONG, DAVID THOMAS · 2016 to 2025
$3.7M
NCI NIH HHS T32 CA193201
6 · The paper itself

Abstract

backgroundThe impact of the COVID-19 pandemic has spread beyond those infected with SARS-CoV-2. Its widespread consequences have affected cancer patients whose surgeries may be delayed in order to minimize exposure and conserve resources.

methodsExperts in each surgical oncology subspecialty were selected to perform a review of the relevant literature. Articles were obtained through PubMed searches in each cancer subtype using the following terms: delay to surgery, time to surgery, outcomes, and survival.

resultsDelays in surgery > 4 weeks in breast cancer, ductal carcinoma in situ, T1 pancreatic cancer, ovarian cancer, and pediatric osteosarcoma, negatively impacted survival. Studies on hepatocellular cancer, colon cancer, and melanoma (Stage I) demonstrated reduced survival with delays > 3 months.

conclusionStudies have shown that short-term surgical delays can result in negative impacts on patient outcomes in multiple cancer types as well as

Indexed as

COVID-19outcomessurgical delayssurgical oncologyTime to surgery

Identifiers

PMID34142081
PMCPMC8208646
OpenAlexW3037937076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.